跳至主要内容
临床试验/NCT01402336
NCT01402336已完成3 期

'A Multicentre, Prospective Randomized Study to Assess the Effect When GnRH Antagonist is Started Either on Stimulation Day 1 and Day 6 vs. Conventional GnRH Agonist Long Protocol in Patients With Polycystic Ovary Syndrome Undergoing IVF-ET

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2011年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
43
试验地点
1
主要终点
number of oocyte retrieved

研究概览

简要总结

GnRH (Gonadotropin-releasing hormone) antagonists in IVF (in vitro fertilization) has been accomplished by several randomized controlled trials compared with conventional GnRH agonist long protocol in polycystic ovary syndrome (PCOS) patients. Moreover, there are debating issues that refer to the timing of GnRH antagonist initiation. The purpose of this study is to investigate the laboratory and clinical priority during ovarian stimulation for IVF in patients with PCOS treated with three different protocols.

详细描述

GnRH Antagonist is Started on Stimulation Day 1 GnRH Antagonist is Started on Stimulation Day 6 Conventional GnRH Agonist Long Protocol

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • PCOS patients (diagnosed as 2003 ASRM(The American Society for Reproductive Medicine)/ESHRE(The European Society of Human Reproduction and Embryology) consensus meeting guideline)
  • age 20-40 years
  • patients who have normal uterus
  • Korean ethnicity

排除标准

  • patients who have abnormal thyroid function
  • patients who have abnormal prolactin test
  • patients who have diabetes, or Cushing's syndrome, or congenital adrenal hyperplasia, or androgen-producing tumor.
  • Patients who reject informed consent
  • patients who have experience of adverse events for GnRH agonist, antagonist, recombinant FSH(follicle-stimulating hormone).

研究组 & 干预措施

GnRH antagonist, SD #1 starting group

Experimental

Start GnRH antagonist from stimulation day 1 during ovulation induction cycles

干预措施: GnRH antagonist (Cetrorelix) (Drug)

GnRH antagonist, SD #6 starting group

Experimental

Start GnRH antagonist from stimulation day 6 during ovulation induction cycles

干预措施: GnRH antagonist (Cetrorelix) (Drug)

Conventional GnRH agonist long group

Active Comparator

Conventional GnRH agonist long protocol

干预措施: Conventional GnRH agonist (Triptorelin) (Drug)

结局指标

主要结局

number of oocyte retrieved

时间窗: ovum pick up day, At the point of ovum pick-up, we can count how many oocyte was retrieved. So, almost just after ovum pick-up, outcome measure will be possible.

次要结局

  • pregnancy rate(after confirming fetal heart beat via transvaginal ultrasound. Usually 2~4 weeks after ovum pick-up day.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Young Min Choi

Young Min Choi

Seoul National University Hospital

研究点 (1)

Loading locations...

相似试验

GnRH Antagonist Versus GnRH Agonist in Polycystic... | 临床试验